Sector: Health Care
Director information for BIOVENTUS CLASS A INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Ajay Dhankar | Chief Corporate Development & Strategy Officer | 55 | ["PhD in Molecular Biophysics and Biochemistry from Yale University","B.S. in Physics and Computer Science from Angelo State University","Experience in the industry","Significant finance and development experience"] | [] | 2026 |
| Ajay Dhankhar | Director | 55 | [] | [] | 2026 |
| Guido J. Neels | Director; Board Member | 77 | ["Operating Partner at EW Healthcare Partners","Former Chief Operating Officer at Guidant Corporation","Former President, Europe, Middle East, Africa and Canada at Guidant","Experience on boards of public companies"] | ["Compensation","Audit and Risk"] | 2026 |
| Guy P. Nohra | Director; Board Member | 66 | ["Extensive experience in the life sciences industry","Investment and development experience","Service as a director of other life sciences companies"] | ["Nominating and Corporate Governance","Compliance, Ethics and Culture"] | 2026 |
| John A. Bartholdson | Director; Chairperson | 55 | ["Co-founder and Partner of Juniper Investment Company","25 years of experience leading and overseeing private and public equity investments","Extensive management oversight","Service on multiple public and private company boards","Deep transactional expertise","Chairman of the board of directors of Lincoln Educational Services Corporation","Chairman of the board of directors of Theragenics Corporation","Previously served on the board of directors of Obagi Medical Products, Inc.","Worked as a Partner of Stonington Partners","Analyst at Merrill Lynch Capital Partners","Bachelor of Arts from Duke University","Master of Business Administration from Stanford University Graduate School of Business"] | ["Compensation (Chairperson)","Compliance, Ethics and Culture","Audit and Risk"] | 2026 |
| Martin P. Sutter | Director; Chairperson | 71 | ["Founding Managing Director of EW Healthcare Partners","More than 35 years of management experience in operations, marketing, finance and venture capital","Experience serving on boards of directors of various life sciences companies"] | ["Nominating and Corporate Governance"] | 2026 |
| Mary Kay Ladone | Director | 59 | ["significant finance","investor relations","talent management","M&A experience at large healthcare companies"] | ["Audit and Risk","Compensation"] | 2026 |
| Michelle McMurry-Heath | Director; Chairperson | 56 | ["MD, PhD, served as President and Chief Operating Officer of the Biotechnology Innovation Organization","Global Head of Evidence Generation for Medical Device Companies at Johnson & Johnson","Vice President of Global External Innovation and Global Leader for Regulatory Sciences at Johnson & Johnson","Associate science director of the FDA's Center for Devices and Radiological Health","Director of the Health, Biomedical Science and Society Policy Program at the Aspen Institute","Senior Policy Advisor for Senator Joseph Lieberman for Health, Social, and Biomedical Innovation Policy"] | ["Compliance, Ethics and Culture"] | 2026 |
| Patrick J. Beyer | Director; President and Chief Executive Officer | 60 | ["Extensive experience in international healthcare markets","Previous service as a chief executive officer","Broad business and public company experience"] | ["Audit and Risk"] | 2026 |
| Philip G. Cowdy | Director | 59 | ["Chief Business Development and Corporate Affairs Officer for Smith & Nephew plc","Executive Vice President of Business Development and Corporate Affairs","Head of Corporate Affairs and Strategic Planning","Group Director of Corporate Affairs","Director of Investor Relations","Senior Director at Deutsche Bank for 13 years","Bachelor of Science in Natural Sciences from Durham University (UK)","Qualified chartered accountant"] | ["Nominating and Corporate Governance","Compliance, Ethics and Culture"] | 2026 |
| Robert E. Claypoole | President, Chief Executive Officer and Director | 54 | ["President and Chief Executive Officer of Bioventus","Former Executive Vice President of Wound Care at Mölnlycke","Experience in leadership positions at Mölnlycke and Medtronic","Global Vice President & General Manager at Medtronic","Formerly served on the board of ZetrOz Inc. and the Association of periOperative Registered Nurses","Bachelor of Arts and Master of Business Administration from Cornell University"] | [] | 2026 |
| Susan M. Stalnecker | Director; Chairperson | 73 | ["Senior Advisor at Boston Consulting Group","Vice President of E.I. duPont de Nemours and Co.","Experience in senior leadership roles including Treasurer & M&A, Risk Management, Government and Consumer Markets, and Productivity & Shared Services","Member of the audit committee at Optimum Funds McQuairie","Experience on the board of directors of Leidos Holding, Inc.","Trustee at the Duke Health System"] | ["Nominating and Corporate Governance","Audit and Risk","Compliance, Ethics and Culture"] | 2026 |
| William A. Hawkins | Chairperson; Director | 72 | ["Senior Advisor to EW Healthcare Partners","Former President and Chief Executive Officer of Immucor, Inc.","Former Chief Executive Officer of Medtronic, Inc.","Former President and Chief Executive Officer of Novoste Corporation","Experience on the board of directors of Biogen Inc. and MiMedx Group Inc.","Former Vice Chair of Duke University Board of Trustees","Master of Business Administration from University of Virginia Darden School of Business","Bachelor of Science in electrical and biomedical engineering from Duke University"] | ["Nominating and Corporate Governance","Compliance, Ethics and Culture"] | 2026 |
